Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Watertown, Massachusetts-based Disc has agreed with the FDA that it will use average monthly time in sunlight during the last ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...

Arcellx (NASDAQ:ACLX) announced an update for its Phase 3 iMMagine-3 study and plans to present Phase 1 and 2 data for its therapy candidate anito-cel for the treatment of multiple myeloma. The ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous infliximab (Zymfentra) showed monotherapy could be as effective as ...

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...

We will begin the MacroGenics 2024 third-quarter corporate progress and financial results conference call in just a moment.

Paramount+ offers exclusive live streams and on-demand replays of all UEFA Champions League matches and when you sign up, you ...

Released on November 1, Singham Again and Bhool Bhulaiyaa 3 are having an intense clash at the box office. Both films are expected to earn Rs 13 crore on Tuesday.